PREPIDIL® Principal Display Panel (dinoprostone) | Pfizer Medical Information

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 3 g Syringe Applicator Label

NDC 0009-3359-01

Prepidil® Gel 0.5 mg*

dinoprostone cervical gel

For endocervical administration
Sterile
DOSAGE AND USE: See accompanying prescribing
information.
* Each 3 gram syringe applicator contains 0.5 mg
dinoprostone. Also contains 240 mg colloidal silicon
dioxide NF, 2760 mg triacetin USP.
Store in a refrigerator 2° to 8°C (36° to 46°F).

Distributed by
Pharmacia & Upjohn Co
Division of Pfizer Inc,
NY, NY 10017
LOT/EXP.:

Rx only
PAA056623

PRINCIPAL DISPLAY PANEL - 3 g Syringe Applicator Label

PRINCIPAL DISPLAY PANEL - 3 g Syringe Label

Prepidil® Gel 0.5 mg

dinoprostone cervical gel

Sterile
Store in a refrigerator 2° to 8°C (36° to 46°F).
One 3 gram syringe

Pfizer Injectables

Distributed by
Pharmacia & Upjohn Co
Division of Pfizer Inc, NY, NY 10017

NDC 0009-3359-01

PAA056625

PRINCIPAL DISPLAY PANEL - 3 g Syringe Label

PRINCIPAL DISPLAY PANEL - 3 gram Syringe Carton

Prepidil® Gel 0.5 mg*

dinoprostone cervical gel

For endocervical administration

Sterile
Package includes 2 shielded catheters - 10 mm tip and 20 mm tip

1–3 gram syringe

Pfizer Injectables

NDC 0009-3359-01

Rx only

PRINCIPAL DISPLAY PANEL - 3 gram Syringe Carton

PRINCIPAL DISPLAY PANEL - 3 g Syringe Bundle Label

NDC 0009-3359-02
Contains 5 of NDC 0009-3359-01

Prepidil® Gel 0.5 mg

dinoprostone cervical gel

5–3 gram syringes

Distributed by
Pharmacia & Upjohn Co
Division of Pfizer Inc, NY, NY 10017

Rx only

PAA056624

PRINCIPAL DISPLAY PANEL - 3 g Syringe Bundle Label

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PREPIDIL® Quick Finder

Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All

INDICATIONS AND USAGE

PREPIDIL Gel is indicated for ripening an unfavorable cervix in pregnant women at or near term with a medical or obstetrical need for labor induction.